Cagrilintide: A Novel Peptide for Enhanced Blood Sugar Management and Weight Loss

Discover the groundbreaking potential of Cagrilintide, an advanced acylated amylin analogue designed to significantly improve blood sugar status and promote effective weight loss. Explore its role in cutting-edge obesity research.

Get a Quote & Sample

Advantages You Gain

Enhanced Efficacy

As a long-acting acylated amylin analogue, Cagrilintide acts as a nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist, offering potent effects for weight loss research.

Appetite Regulation

Cagrilintide has demonstrated the ability to significantly reduce food intake, making it a valuable tool in the study and management of obesity.

High Purity & Quality

Our Cagrilintide product boasts a purity of over 99% and is supplied as a white freeze-dried powder, meeting stringent quality standards for pharmaceutical research.

Key Applications

Obesity Research

Investigate the mechanisms behind weight management and appetite control through studies focusing on obesity research with Cagrilintide.

Metabolic Health Studies

Examine the impact on blood sugar levels and overall metabolic status, crucial for understanding conditions like type 2 diabetes.

Pharmaceutical Intermediate

Utilize Cagrilintide as a high-quality pharmaceutical intermediate in the development of novel therapeutics.

Peptide Drug Development

Incorporate this advanced peptide into research for new peptide drugs, benefiting from its long-acting properties and safe delivery.